Showing 1 - 20 results of 24 for search 'Peter Mu‐Hsin Chang', query time: 0.09s
Refine Results
-
1
-
2
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer by Yu-Chan Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Chien-Hsiu Li, Ming-Hsien Chan, Yi-Jang Lee, Ming-Huang Chen, Ming-Huang Chen, Michael Hsiao, Michael Hsiao
Published 2022-01-01
Article -
3
Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics by Jiun-I Lai, Jiun-I Lai, Jiun-I Lai, Yu-Jhen Tseng, Ming-Huang Chen, Ming-Huang Chen, Ming-Huang Chen, Chi-Ying F. Huang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang
Published 2020-11-01
Article -
4
Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling by Li-Jie Li, Li-Jie Li, Chien-Hsiu Li, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Tsung-Ching Lai, Tsung-Ching Lai, Chen-Yin Yong, Sheng-Wei Feng, Sheng-Wei Feng, Michael Hsiao, Michael Hsiao, Wei-Min Chang, Chi-Ying F. Huang, Chi-Ying F. Huang
Published 2022-07-01
Article -
5
-
6
Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast c... by Jia-Hong Chen, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, Peter Mu-Hsin Chang, Tsu-Yi Chao, Tse-Hung Huang
Published 2019-06-01
Article -
7
-
8
-
9
-
10
Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner by Thi-Huong Nguyen, Thi-Huong Nguyen, Huey-Jiun Ko, Huey-Jiun Ko, Po-Yu Tsai, Po-Yu Tsai, Tai-Shan Cheng, Thu-Ha Tran, Ly Hien Doan, Ly Hien Doan, Michael Hsiao, Michael Hsiao, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Hsiao-Sheng Liu, Hsiao-Sheng Liu, Yi-Ren Hong, Yi-Ren Hong, Chi-Ying F. Huang, Chi-Ying F. Huang
Published 2024-10-01
Article -
11
-
12
-
13
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis by Yu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, Chia-Yi Su, Yuang-Feng Lin, Chi-Long Chen, Ming-Huang Chen, Peter Mu-Hsin Chang, Alex T. H. Wu, Michael Hsiao
Published 2017-01-01
Article -
14
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis by Li-Jie Li, Peter Mu-Hsin Chang, Chien-Hsiu Li, Yu-Chan Chang, Tsung-Ching Lai, Chia-Yi Su, Chi-Long Chen, Wei-Min Chang, Michael Hsiao, Sheng-Wei Feng
Published 2022-03-01
Article -
15
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma by Tien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, Ling-Wei Wang, Shyh-Kuan Tai, Pen-Yuan Chu, Wen-Liang Lo, Cheng-Hsien Wu, Muh-Hwa Yang, Peter Mu-Hsin Chang
Published 2022-12-01
Article -
16
Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a. by Hua-Qing Wu, Mei-Ling Cheng, Jin-Mei Lai, Hsuan-Hui Wu, Meng-Chun Chen, Wen-Huan Liu, Wu-Hsiung Wu, Peter Mu-Hsin Chang, Chi-Ying F Huang, Ann-Ping Tsou, Ming-Shi Shiao, Feng-Sheng Wang
Published 2017-07-01
Article -
17
Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma. by Ming-Huang Chen, Wu-Lung R Yang, Kuan-Ting Lin, Chia-Hung Liu, Yu-Wen Liu, Kai-Wen Huang, Peter Mu-Hsin Chang, Jin-Mei Lai, Chun-Nan Hsu, Kun-Mao Chao, Cheng-Yan Kao, Chi-Ying F Huang
Published 2011-01-01
Article -
18
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway by Shin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, Yu-Chan Chang, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F. Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen
Published 2021-07-01
Article -
19
BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death by Huey-Jiun Ko, Shean-Jaw Chiou, Cheng-Yu Tsai, Joon-Khim Loh, Xin-Yi Lin, Thu-Ha Tran, Chia-Chung Hou, Tai-Shan Cheng, Jin-Mei Lai, Peter Mu-Hsin Chang, Feng-Sheng Wang, Chun-Li Su, Chi-Ying F. Huang, Yi-Ren Hong
Published 2022-12-01
Article -
20
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer by Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang, Yu-Tang Huang, Anh Thuc Nguyen, Ian Yi‑Feng Chang, Yi-Tung Chen, Hao-Wen Hsieh, Yue-Li Juang, Peter Mu-Hsin Chang, Tzu-Yi Huang, Ying-Chih Chang, Yuh-Min Chen, Hsuan Liu, Chi-Ying F. Huang
Published 2025-01-01
Article